Literature DB >> 1786617

Onchocerciasis distribution and severity in five West African countries.

G De Sole1, R Baker, K Y Dadzie, J Giese, P Guillet, F M Keita, J Remme.   

Abstract

The Onchocerciasis Control Programme in West Africa recently extended its operation to Guinea, Guinea-Bissau, the western part of Mali, Senegal and Sierra Leone. To estimate the number of people infected and blinded by the disease and to determine its distribution and severity in the extension area, 215 villages were selected, using a stratified random sampling procedure, and surveyed. All the relevant entomological information available at the time was used in the sampling procedure and in the selection of 92 non-representative villages that were surveyed to confirm the findings. In addition, the populations of 608 villages were examined to map out in detail the distribution of onchocerciasis in the areas at a high risk of onchocercal blindness. The study estimated that 1,475,367 people were infected and 23,728 were blinded from onchocerciasis out of a rural population of 4,464,183. The northern and western part of the study area and the lower Niger basin presented a low or no risk of onchocercal blindness. The upper Niger basin, the south-central part of Sierra Leone, and three small foci in the Gambia, Bakoye, and lower Niger river basins were areas with a high risk of onchocercal blindness. The other parts of the study area presented a medium risk of onchocercal blindness. By detecting the communities at risk of onchocercal disease this study permits the selection of populations for disease control based on mass distribution of ivermectin, a microfilaricide.

Entities:  

Mesh:

Year:  1991        PMID: 1786617      PMCID: PMC2393320     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  [STUDIES ON THE INCIDENCE AND SIGNIFICANCE OF ONCHOCEROSIS IN GUINEA, WEST AFRICA].

Authors:  H J KNUETTGEN
Journal:  Z Tropenmed Parasitol       Date:  1964-12

2.  Onchocerciasis in Sierra Leone.2: A comparison of forest and savanna villages.

Authors:  J E McMahon; S I Sowa; G H Maude; B R Kirkwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  Epidemiological studies of onchocerciasis in savanna villages of Sierra Leone.

Authors:  J E McMahon; S I Sowa; G H Maude; C M Hudson; B R Kirkwood
Journal:  Trop Med Parasitol       Date:  1988-09

4.  [Epidemiologic status of onchocerciasis].

Authors:  A Prost; J P Hervouet; B Thylefors
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

5.  Detailed epidemiological mapping of three onchocerciasis foci in West Africa.

Authors:  G De Sole; J Giese; F M Keita; J Remme
Journal:  Acta Trop       Date:  1991-01       Impact factor: 3.112

6.  [Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl)].

Authors:  A Prost; J Prod'hon
Journal:  Med Trop (Mars)       Date:  1978 Sep-Oct

7.  A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area.

Authors:  J Remme; O Ba; K Y Dadzie; M Karam
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Onchocerciasis in Sierra Leone 3: Relationships between eye lesions and microfilarial prevalence and intensity.

Authors:  J E McMahon; S I Sowa; G H Maude; B R Kirkwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

  8 in total
  7 in total

1.  Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.

Authors:  P Guillet; A Sékétéli; E S Alley; H Agoua; B A Boatin; Y Bissan; L K Akpoboua; D Quillévéré; E M Samba
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 2.  Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.

Authors:  Gebremedhin Gebrezgabiher; Zeleke Mekonnen; Delenasaw Yewhalaw; Asrat Hailu
Journal:  Infect Dis Poverty       Date:  2019-07-04       Impact factor: 10.485

Review 3.  Genomic Epidemiology in Filarial Nematodes: Transforming the Basis for Elimination Program Decisions.

Authors:  Shannon M Hedtke; Annette C Kuesel; Katie E Crawford; Patricia M Graves; Michel Boussinesq; Colleen L Lau; Daniel A Boakye; Warwick N Grant
Journal:  Front Genet       Date:  2020-01-09       Impact factor: 4.599

4.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

5.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.

Authors:  Honorat G M Zouré; Mounkaila Noma; Afework H Tekle; Uche V Amazigo; Peter J Diggle; Emanuele Giorgi; Jan H F Remme
Journal:  Parasit Vectors       Date:  2014-07-22       Impact factor: 3.876

6.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.

Authors:  Mounkaila Noma; Honorat G M Zouré; Afework H Tekle; Peter A I Enyong; Bertram E B Nwoke; Jan H F Remme
Journal:  Parasit Vectors       Date:  2014-07-22       Impact factor: 3.876

7.  Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa.

Authors:  Simon J O'Hanlon; Hannah C Slater; Robert A Cheke; Boakye A Boatin; Luc E Coffeng; Sébastien D S Pion; Michel Boussinesq; Honorat G M Zouré; Wilma A Stolk; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2016-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.